您的购物车当前为空
EGFRmutant-IN-2 (Compound D51) 作为一种EGFR突变抑制剂,展现出对抑制EGFRL858R/T790M/C797S及EGFRdel19/T790M/C797S突变体具有高效能,其IC50值分别为14 nM和62 nM。该化合物不仅具备优良的药代动力学参数和安全特性,还表现出在体内稳定性和抗肿瘤的活性。

EGFRmutant-IN-2 (Compound D51) 作为一种EGFR突变抑制剂,展现出对抑制EGFRL858R/T790M/C797S及EGFRdel19/T790M/C797S突变体具有高效能,其IC50值分别为14 nM和62 nM。该化合物不仅具备优良的药代动力学参数和安全特性,还表现出在体内稳定性和抗肿瘤的活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 25 mg | ¥ 10,600 | 6-8周 | |
| 50 mg | ¥ 13,800 | 6-8周 | |
| 100 mg | ¥ 17,500 | 6-8周 |
EGFR mutant-IN-2 相关产品
| 产品描述 | EGFR mutant-IN-2 (Compound D51) is an inhibitor of EGFR mutants, specifically targeting EGFR L858R/T790M/C797S and EGFR del19/T790M/C797S mutants with IC50 values of 14 nM and 62 nM, respectively. This compound exhibits favorable pharmacokinetic (PK) parameters, safety properties, in vivo stability, and demonstrates antitumor activity [1]. |
| 分子量 | 556.6 |
| 分子式 | C27H27F3N6O2S |
| CAS No. | 2770009-06-6 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
评论内容